We are live on ! Find out more
Citigroup

Citigroup Portfolio holdings

AUM $235B
1-Year Est. Return 32.99%
 

Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.

This Fund
S&P 500
This Quarter Est. Return
-14.86%
1 Year Est. Return
+32.99%
3 Year Est. Return
+97.19%
5 Year Est. Return
+117.91%
10 Year Est. Return
+456.21%
AUM
$134B
AUM Growth
-$30.1B
Cap. Flow
-$1.57B
Cap. Flow %
-1.17%
Top 10 Hldgs %
29.15%
Holding
6,955
New
507
Increased
2,096
Reduced
2,889
Closed
579

Sector Composition

Rank Sector Weight
1 Technology 10.07%
2 Financials 5.69%
3 Healthcare 5.49%
4 Consumer Discretionary 4.41%
5 Industrials 3.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FRWAW
5576
CALL
DELISTED
PWP Forward Acquisition Corp. I Warrant
FRWAW
$4K ﹤0.01%
20,001
PHAS
5577
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$4K ﹤0.01%
+6,000
New +$5.74K
HTAQ.WS
5578
CALL
DELISTED
Hunt Companies Acquisition Corp. I Warrants, each exercisable for one Class A ordinary share at an exercise price of $11.50 per share
HTAQ.WS
$4K ﹤0.01%
25,301
PSTH.WS
5579
CALL
DELISTED
Pershing Square Tontine Holdings, Ltd. Warrants, exercisable for one share of Class A Common Stock f
PSTH.WS
$4K ﹤0.01%
+10,330
New +$6.9K
ACTG icon
5580
Acacia Research
ACTG
$447M
$3K ﹤0.01%
501
-1,610
-76% -$7.38K
ADVM
5581
DELISTED
Adverum Biotechnologies
ADVM
$3K ﹤0.01%
241
-354
-59% -$3.71K
ALDX icon
5582
CALL
Aldeyra Therapeutics
ALDX
$95.3M
$3K ﹤0.01%
800
AMPG icon
5583
AmpliTech
AMPG
$124M
$3K ﹤0.01%
1,500
+539
+56% +$1.22K
AOR icon
5584
iShares Core 60/40 Balanced Allocation ETF
AOR
$3.65B
$3K ﹤0.01%
+67
New +$3.37K
AUTL
5585
Autolus Therapeutics
AUTL
$386M
$3K ﹤0.01%
957
-279
-23% -$849
BDTX icon
5586
Black Diamond Therapeutics
BDTX
$101M
$3K ﹤0.01%
1,054
-908
-46% -$2.11K
BKSY icon
5587
BlackSky Technology
BKSY
$898M
$3K ﹤0.01%
187
-211
-53% -$3.22K
CCRD
5588
DELISTED
CoreCard
CCRD
$3K ﹤0.01%
97
-325
-77% -$7.67K
CIX icon
5589
Comp X International
CIX
$346M
$3K ﹤0.01%
119
+22
+23% +$492
CTMX icon
5590
CytomX Therapeutics
CTMX
$701M
$3K ﹤0.01%
1,677
-2,648
-61% -$5.07K
CTRM icon
5591
Castor Maritime
CTRM
$18.3M
$3K ﹤0.01%
242
+142
+142% +$2.63K
CULP icon
5592
Culp Inc
CULP
$45.1M
$3K ﹤0.01%
+800
New +$4.91K
CYD icon
5593
China Yuchai International
CYD
$1.74B
$3K ﹤0.01%
+301
New +$3.13K
EVOK
5594
DELISTED
Evoke Pharma
EVOK
$3K ﹤0.01%
+68
New +$3.24K
FNDF icon
5595
Schwab Fundamental International Large Company Index ETF
FNDF
$24.4B
$3K ﹤0.01%
120
GLDM icon
5596
SPDR Gold MiniShares Trust
GLDM
$27.4B
$3K ﹤0.01%
83
GLMD icon
5597
Galmed Pharmaceuticals
GLMD
$4.41M
$3K ﹤0.01%
21
+17
+425% +$2.82K
VIP
5598
Vulcan Infrastructure and Power Inc. Class A Common Stock
VIP
$38.1M
$3K ﹤0.01%
129
-2,056
-94% -$116K
HOWL icon
5599
Werewolf Therapeutics
HOWL
$21.8M
$3K ﹤0.01%
736
-1,946
-73% -$8.88K
HROW icon
5600
Harrow
HROW
$1.47B
$3K ﹤0.01%
395
-169
-30% -$1.14K

Similar funds

Citigroup's Q2 2022 Portfolio in Review

As of Q2 2022, Citigroup held 6,955 positions worth $134B, down 18% from $165B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Citigroup's Q2 2022 filing shows 507 new, 2,096 increased, 2,889 reduced and 579 closed positions. Its largest new stake was State Street SPDR MarketAxess Investment Grade 400 Corporate Bond ETF: 250,000 shares worth $24.7M. The largest sale was iShares Russell 2000 ETF, an estimated $565M.

By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 12% a quarter earlier, followed by Financials and Healthcare.

  • Citigroup's largest Q2 2022 buy was State Street SPDR MarketAxess Investment Grade 400 Corporate Bond ETF: 250,000 shares worth $24.7M.
  • Citigroup added most to Invesco QQQ Trust in Q2 2022, an estimated $628M increase.
  • Citigroup's biggest Q2 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $565M.
  • Citigroup fully exited People's United Financial Inc in Q2 2022, selling an estimated $103M.
  • Citigroup's ten largest holdings make up 29% of its $134B portfolio in Q2 2022.
  • Citigroup opened 507 new positions and closed 579 in Q2 2022.
  • Citigroup's portfolio value fell 18% quarter-over-quarter to $134B.

Based on Citigroup's 13F filing for Q2 2022, filed 10 Aug 2022.